# SER100 in Isolated Systolic Hypertension

> **NCT01987284** · PHASE2 · COMPLETED · sponsor: **Serodus AS** · enrollment: 17 (actual)

## Conditions studied

- Isolated Systolic Hypertension

## Interventions

- **DRUG:** SER100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01987284
- **Lead sponsor:** Serodus AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-10-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987284, "SER100 in Isolated Systolic Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01987284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*